Repro Med Systems Inc
NASDAQ:KRMD

Watchlist Manager
Repro Med Systems Inc Logo
Repro Med Systems Inc
NASDAQ:KRMD
Watchlist
Price: 3.52 USD -1.68% Market Closed
Market Cap: 161.4m USD
Have any thoughts about
Repro Med Systems Inc?
Write Note

Repro Med Systems Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Repro Med Systems Inc
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Repro Med Systems Inc
NASDAQ:KRMD
Operating Income
-$10.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Operating Income
$2.9B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
6%
Boston Scientific Corp
NYSE:BSX
Operating Income
$2.9B
CAGR 3-Years
20%
CAGR 5-Years
10%
CAGR 10-Years
11%
Stryker Corp
NYSE:SYK
Operating Income
$4.8B
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Operating Income
$6.9B
CAGR 3-Years
-7%
CAGR 5-Years
10%
CAGR 10-Years
11%
Intuitive Surgical Inc
NASDAQ:ISRG
Operating Income
$2.1B
CAGR 3-Years
5%
CAGR 5-Years
10%
CAGR 10-Years
14%
No Stocks Found

Repro Med Systems Inc
Glance View

Market Cap
160.8m USD
Industry
Health Care

Repro-Med Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. The company is headquartered in Chester New York, New York and currently employs 77 full-time employees. The company is focused on the developing, manufacturing, and commercializing of specialty infusion solutions. The firm's products include the FREEDOM Infusion Systems, which consist of the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgHFlo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The FREEDOM System operates at a lower pressure and maintains a balance between what a patient’s subcutaneous tissues can absorb and what the system delivers. The firm performs product assembly, calibration, pre- and post-assembly quality control inspection and testing, and final packaging for all its products at its Chester, New York facility.

KRMD Intrinsic Value
3.16 USD
Overvaluation 10%
Intrinsic Value
Price

See Also

What is Repro Med Systems Inc's Operating Income?
Operating Income
-10.3m USD

Based on the financial report for Dec 31, 2023, Repro Med Systems Inc's Operating Income amounts to -10.3m USD.

What is Repro Med Systems Inc's Operating Income growth rate?
Operating Income CAGR 1Y
5%

Over the last year, the Operating Income growth was 5%.

Back to Top